Effects of Morning vs Afternoon Resistance Exercise on Blood Sugar in Type 1 Diabetes
Timing of Resistance Exercise, Glucose Control and Exercise Adaptations in People With Type 1 Diabetes: a Randomised-controlled Trial
NA · Dasman Diabetes Institute · NCT05884814
This study tests whether doing resistance exercise in the morning or afternoon helps people with type 1 diabetes better control their blood sugar and improve their overall health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 54 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Dasman Diabetes Institute (other) |
| Locations | 1 site (Kuwait City) |
| Trial ID | NCT05884814 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effects of resistance exercise performed in the morning versus the afternoon on blood glucose levels and cardiometabolic health outcomes in individuals with type 1 diabetes. Participants will engage in either morning or afternoon exercise sessions, and their blood glucose levels will be monitored to assess the impact of timing on glucose control. The study will also evaluate overall health improvements related to exercise timing. The research is being conducted at the Dasman Diabetes Institute in Kuwait City.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with type 1 diabetes for at least one year who have stable insulin therapy.
Not a fit: Patients with a BMI of 45 or higher, severe autonomic neuropathy, or other medical conditions that prevent safe exercise may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into optimal exercise timing for better blood glucose management in patients with type 1 diabetes.
How similar studies have performed: While there is ongoing research into exercise and diabetes management, this specific comparison of exercise timing in type 1 diabetes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Physician confirmed type 1 diabetes for at least 1 year * Stable insulin therapy for 3 months prior to the study Exclusion Criteria: * BMI of 45 or higher * BP of 160/100mmHg or higher * autonomic neuropathy * severe proliferative retinopathy * joint or limb injuries preventing weight-bearing activity * autonomic neuropathy * severe proliferative retinopathy * any other medical condition that prevents participants from exercising safely.
Where this trial is running
Kuwait City
- Dasman Diabetes Institute — Kuwait City, Kuwait (RECRUITING)
Study contacts
- Study coordinator: Ebaa AlOzairi, MBChB
- Email: ebaa.alozairi@dasmaninstitute.rog
- Phone: +965 22242999
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 1 Diabetes, exercise, circadian rhythm, glucose control, muscle, strength